AU3580001A - Modulators of the endocannabinoid uptake and of the vallinoid receptors - Google Patents

Modulators of the endocannabinoid uptake and of the vallinoid receptors

Info

Publication number
AU3580001A
AU3580001A AU35800/01A AU3580001A AU3580001A AU 3580001 A AU3580001 A AU 3580001A AU 35800/01 A AU35800/01 A AU 35800/01A AU 3580001 A AU3580001 A AU 3580001A AU 3580001 A AU3580001 A AU 3580001A
Authority
AU
Australia
Prior art keywords
vallinoid
endocannabinoid
modulators
uptake
receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35800/01A
Inventor
David Baker
Tiziana Bisogno
Luciano De Petrocellis
Vincenzo Di Marzo
Gareth Pryce
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
London University College
Original Assignee
London University College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB0004895 priority Critical
Priority to GB0004895A priority patent/GB0004895D0/en
Priority to GB0027989 priority
Priority to GB0027989A priority patent/GB0027989D0/en
Application filed by London University College filed Critical London University College
Priority to PCT/GB2001/000858 priority patent/WO2001064212A1/en
Publication of AU3580001A publication Critical patent/AU3580001A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
AU35800/01A 2000-03-01 2001-02-28 Modulators of the endocannabinoid uptake and of the vallinoid receptors Abandoned AU3580001A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB0004895 2000-03-01
GB0004895A GB0004895D0 (en) 2000-03-01 2000-03-01 Inhibitor
GB0027989 2000-11-16
GB0027989A GB0027989D0 (en) 2000-11-16 2000-11-16 Modulator
PCT/GB2001/000858 WO2001064212A1 (en) 2000-03-01 2001-02-28 Modulators of the endocannabinoid uptake and of the vallinoid receptors

Publications (1)

Publication Number Publication Date
AU3580001A true AU3580001A (en) 2001-09-12

Family

ID=26243768

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35800/01A Abandoned AU3580001A (en) 2000-03-01 2001-02-28 Modulators of the endocannabinoid uptake and of the vallinoid receptors

Country Status (2)

Country Link
AU (1) AU3580001A (en)
WO (1) WO2001064212A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266989A1 (en) 2003-01-28 2004-12-30 Currie Mark G Methods and compositions for the treatment of gastrointestinal disorders
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2998314A1 (en) 2007-06-04 2016-03-23 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2009149279A2 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
MX2011007024A (en) 2008-12-31 2011-09-27 Aedelyx Inc Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders.
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
EP2887964B1 (en) 2012-08-21 2019-07-03 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CN105392483B (en) 2013-04-12 2019-03-15 阿德利克斯公司 For inhibiting the NHE3 binding compounds and method of phosphate cotransporter
JP2016522216A (en) 2013-06-05 2016-07-28 シナジー ファーマシューティカルズ インコーポレイテッド Ultra high purity agonist of guanylate cyclase C, method for producing and using the same
CA3049679A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Inhibitors of nhe-mediated antiport
AU2018205400A1 (en) 2017-01-09 2019-07-18 Ardelyx, Inc. Compounds useful for treating gastrointestinal tract disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
JP2002517479A (en) * 1998-06-09 2002-06-18 ザ・ユニバ−シティ・オブ・コネチカット Anandamide transporter inhibitors as analgesic
HN1998000027A (en) * 1998-08-19 1999-06-02 Bayer Ip Gmbh Aryl sulfonamides and analagos
US6509005B1 (en) * 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler

Also Published As

Publication number Publication date
WO2001064212A1 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
EP1674107B8 (en) Use of daptomycin
AU2001274851A2 (en) Electrokinetic delivery device
PL356030A1 (en) Fulvestrant formulation
AU2001252890A1 (en) Microfabricated devices for the storage and selective exposure of chemicals and devices
EP1420796A4 (en) Androgen receptor modulators and methods of use thereof
EP1572890A4 (en) Slc7s as modifies of the p53 pathway and methods of use
AU9486901A (en) Coated medical devices
AU1129902A (en) Coated medical devices
ZA200308863B (en) Modulators of peroxisome proliferator activated receptors.
AU2002246690A1 (en) Annulus- reinforcing band
AU743702C (en) Massage device
AU2002331621A1 (en) 2H-phthalazin-1-ones and methods for use thereof
AU2544201A (en) Implantable device
AU4790501A (en) 2-alkylidene-19-nor-vitamin d compounds and their therapeutic uses
AU2001264256A1 (en) Plaster
AU8086501A (en) Anticonvulsant derivatives useful for the treatment of depression
AU3453102A (en) Device for regulated application of adhesives and/or sealants
AU2002258063A1 (en) Medicament applicator
AU2002211299A1 (en) Coated medical devices
AU2001275445A1 (en) 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications
AU2001281792A1 (en) The use of resveratrol as sunscreen
AU2002234643A1 (en) Amphoteric liposomes and the use thereof
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
AU1309401A (en) Micro-bubble generating nozzle and application device therefor
AU4046701A (en) Device for fixing earphones and/or mini-microphones

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase